Ideal Support for Pre-clinical and Clinical Research Data
PharmaPendium is the only research solution that brings together excerpted pre-clinical, clinical and post-release safety data in a single longitudinal database and offers regulatory context with 2.2 million searchable pages of FDA approval packages. This extensive drug discovery content also includes EMA EPARs, historical data and unique pre-clinical study information that have not been published anywhere else to help support critical drug safety decisions.
Support for faster drug development
PharmaPendium’s comprehensive preclinical to post marketing data extracted from FDA & EMA approval documents helps translational research investigators examine and apply regulatory precedents to drugs in development.
Increased access to regulatory documents
The optional Pharmacokinetics Module gives you even greater access to pre-clinical and clinical exposure data extracted from the entire history of FDA Approval Packages and EMA documents.
Reveal drug-metabolizing enzyme and transporter effects
The optional Metabolizing Enzymes and Transporters Module provides unique data for the modeling of adverse reactions that result from the effects of drug-metabolizing enzymes and transporters.
Insight into your search results
PharmaPendium has features to support the analysis and assessment of results obtained from in vitro and in vivo tests. Compare your drug candidate with approved drugs, adverse effects and species specificity across drugs and drug classes. This data supports crucial decisions about the need for secondary testing.